Moderna, Inc. (MRNA) stock analysis
MRNA · Moderna, Inc.
Latest recorded price: USD 215.27
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth -53.4%, free cash flow margin -106.2%, ROIC -59.7%. The model flags 3 risk signals for this company (2 high severity).